NAPOLI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.368
EU - Europa 1.173
AS - Asia 252
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.794
Nazione #
US - Stati Uniti d'America 1.363
PL - Polonia 630
IE - Irlanda 171
SE - Svezia 135
HK - Hong Kong 113
IT - Italia 94
CN - Cina 56
JO - Giordania 44
DE - Germania 42
FI - Finlandia 25
GB - Regno Unito 19
CH - Svizzera 14
VN - Vietnam 13
BE - Belgio 12
ES - Italia 11
SG - Singapore 11
AT - Austria 7
TR - Turchia 7
IN - India 6
CA - Canada 5
RU - Federazione Russa 4
UA - Ucraina 4
DK - Danimarca 2
NL - Olanda 2
EU - Europa 1
ID - Indonesia 1
IR - Iran 1
PT - Portogallo 1
Totale 2.794
Città #
Warsaw 628
Chandler 176
Dublin 171
Fairfield 163
Ashburn 124
Cambridge 95
Ann Arbor 83
Seattle 82
Houston 78
Hong Kong 74
Woodbridge 72
Wilmington 59
Beijing 40
Princeton 35
Altamura 34
Bremen 31
Lawrence 31
Buffalo 29
Florence 29
Boston 21
Boardman 20
Medford 17
San Diego 17
Bern 14
New York 14
Shanghai 14
Barcelona 11
Brussels 11
Falls Church 7
Jacksonville 7
Vienna 7
Dong Ket 6
Phoenix 6
Singapore 6
West Jordan 6
Norwalk 5
Pune 5
Toronto 5
Redmond 4
Helsinki 3
Hillsboro 3
Izmir 3
Kent 3
Lappeenranta 3
Latina 3
Washington 3
Copenhagen 2
Philadelphia 2
Radomsko 2
Sesto Fiorentino 2
Andover 1
Aprilia 1
Arezzo 1
Atlanta 1
Baotou 1
Bologna 1
Central District 1
Hounslow 1
Kilburn 1
Kunming 1
Laurel 1
Lisbon 1
London 1
Los Angeles 1
Lucca 1
Miami 1
Moscow 1
Naaldwijk 1
New Bedfont 1
Oggiono 1
Paceco 1
Palermo 1
Redwood City 1
Tappahannock 1
Udine 1
Valdobbiadene 1
Totale 2.292
Nome #
RNA sequencing reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 242
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 218
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 206
Druggable Targets in Pancreatic Adenocarcinoma 194
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 161
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 143
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 108
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 101
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 98
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 84
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 82
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 81
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 77
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 66
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 64
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 62
Pharmacological modulation of protein kinase C for overcoming drug resistance in colorectal cancer. Preliminary results of in vitro studies. 59
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 58
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 58
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 56
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 55
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 54
PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients 52
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 48
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 44
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 37
Expression of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) genes by polymerase chain reaction (PCR) in gastric cancer patients (PTS): preliminary results 35
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) 34
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 34
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 28
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles 27
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 26
The role of thymidylate synthase (TS) expression in prognosis and outcome of 5-fluorouracil (5-FU)-based chemotherapy in patients (pts) with colorectal cancer (CC) 24
Molecular analysis of the FHIT gene in human sporadic colon cancers. 21
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 21
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 19
Preliminary results of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression analysis by polymerase chain reaction (PCR) in gastric cancer patients (PTS) 19
Marked variation thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer 18
Quantitation of intratumoral thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression by the Polymerase Chain Reaction (PCR): marked variation among human colorectal cancer patients 18
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 17
Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells 4
Totale 2.853
Categoria #
all - tutte 8.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.123


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019108 0 0 0 0 0 0 0 0 0 0 62 46
2019/2020622 45 56 20 44 74 64 72 72 60 46 61 8
2020/2021364 34 40 1 49 19 31 34 21 38 45 29 23
2021/2022242 6 22 11 13 7 16 6 26 15 12 39 69
2022/2023818 59 128 40 80 63 140 105 49 104 3 18 29
2023/2024295 7 26 43 10 18 48 30 88 6 15 4 0
Totale 2.853